Back to Journals » Neuropsychiatric Disease and Treatment » Volume 11

Coping strategies and quality of life in schizophrenia: cross-sectional study

Authors Holubova M, Prasko J, Hruby R, Kamaradova D, Ociskova M, Latalova K, Grambal A

Received 17 September 2015

Accepted for publication 13 October 2015

Published 10 December 2015 Volume 2015:11 Pages 3041—3048

DOI https://doi.org/10.2147/NDT.S96559

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Chin-Pang Lee

Peer reviewer comments 3

Editor who approved publication: Dr Roger Pinder

Michaela Holubova,1 Jan Prasko,1,2 Radovan Hruby,3 Dana Kamaradova,1,2 Marie Ociskova,1,2 Klara Latalova,1,2 Ales Grambal1,2

1Department of Psychiatry, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic; 2Department of Psychiatry, University Hospital Olomouc, Czech Ministry of Health, Olomouc, Czech Republic; 3Psychiatric Outpatient Department, Martin, Slovak Republic

Background: The modern psychiatric view of schizophrenia spectrum disorders and their treatment has led to an increasing focus on coping strategies and the quality of life of these patients. In the present study, the authors examined the relationship between demographic data, the severity of symptoms, coping strategies, and the quality of life in psychotic patients. It is important to study the inner experience and striving of these individuals as it has been linked to their well-being and treatment adherence.
Methods: Psychiatric outpatients who met International Classification of Diseases, Tenth Revision criteria for a psychotic disorder (schizophrenia, schizoaffective disorder, or delusional disorder) were recruited in the study. Questionnaires measuring the coping strategies (The Stress Coping Style Questionnaire [SVF-78]), the quality of life (Quality of Life Satisfaction and Enjoyment Questionnaire [Q-LES-Q]), and symptom severity (objective and subjective Clinical Global Impression – objCGI; subjCGI) were assessed. The data were analyzed using one-way analysis of variance, Mann–Whitney U test, Pearson and Spearman correlation coefficients, and multiple regression analysis.
Results: A total of 109 psychotic patients were included in the study. The quality of life was significantly related to both the positive and negative coping strategies. The severity of disorder was highly negatively correlated with the quality of life score. The results of multiple stepwise regression analysis using the quality of life as a dependent variable showed that symptom severity (subjCGI, difference between subjCGI, and objCGI), negative coping strategies, positive coping strategies, and the difference between positive and negative coping strategies explain more than half variance.
Conclusion: Our study suggests the importance of utilizing the positive coping strategies in improving the quality of life in patients with psychotic disorders.

Keywords:
quality of life, coping strategies, psychotic disorders, schizophrenia, severity of the disorder

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Quality of life and coping strategies of outpatients with a depressive disorder in maintenance therapy – a cross-sectional study

Holubova M, Prasko J, Ociskova M, Grambal A, Slepecky M, Marackova M, Kamaradova D, Zatkova M

Neuropsychiatric Disease and Treatment 2018, 14:73-82

Published Date: 22 December 2017

Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study

Vrbova K, Prasko J, Ociskova M, Kamaradova D, Marackova M, Holubova M, Grambal A, Slepecky M, Latalova K

Neuropsychiatric Disease and Treatment 2017, 13:567-576

Published Date: 23 February 2017

Self-stigma and schizophrenia: a cross-sectional study

Vrbova K, Prasko J, Holubova M, Kamaradova D, Ociskova M, Marackova M, Latalova K, Grambal A, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:3011-3020

Published Date: 24 November 2016

Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders – a cross-sectional study

Holubova M, Prasko J, Matousek S, Latalova K, Marackova M, Vrbova K, Grambal A, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:3021-3030

Published Date: 24 November 2016

Self-stigma and quality of life in patients with depressive disorder: a cross-sectional study

Holubova M, Prasko J, Ociskova M, Marackova M, Grambal A, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2677-2687

Published Date: 19 October 2016

Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders

Prasko J, Grambal A, Kasalova P, Kamaradova D, Ociskova M, Holubova M, Vrbova K, Sigmundova Z, Latalova K, Slepecky M, Zatkova M

Neuropsychiatric Disease and Treatment 2016, 12:2659-2676

Published Date: 17 October 2016

Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder

Prasko J, Ociskova M, Grambal A, Sigmundova Z, Kasalova P, Marackova M, Holubova M, Vrbova K, Latalova K, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2539-2552

Published Date: 7 October 2016

Self-stigma in borderline personality disorder – cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders

Grambal A, Prasko J, Kamaradova D, Latalova K, Holubova M, Marackova M, Ociskova M, Slepecky M

Neuropsychiatric Disease and Treatment 2016, 12:2439-2448

Published Date: 22 September 2016

Delirium as a complication of the surgical intensive care

Horacek R, Krnacova B, Prasko J, Latalova K

Neuropsychiatric Disease and Treatment 2016, 12:2425-2434

Published Date: 22 September 2016

Quality of life in borderline patients comorbid with anxiety spectrum disorders – a cross-sectional study

Grambal A, Prasko J, Kamaradova D, Latalova K, Holubova M, Sedláčková Z, Hruby R,

Patient Preference and Adherence 2016, 10:1421-1433

Published Date: 1 August 2016

Coping strategies and self-stigma in patients with schizophrenia-spectrum disorders

Holubova M, Prasko J, Hruby R, Latalova K, Kamaradova D, Marackova M, Slepecky M, Gubova T

Patient Preference and Adherence 2016, 10:1151-1158

Published Date: 24 June 2016

Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients

Ociskova M, Prasko J, Latalova K, Kamaradova D, Grambal A

Neuropsychiatric Disease and Treatment 2016, 12:1539-1551

Published Date: 24 June 2016

Unmet needs of bipolar disorder patients

Hajda M, Prasko J, Latalova K, Hruby R, Ociskova M, Holubova M, Kamaradova D, Mainerova B

Neuropsychiatric Disease and Treatment 2016, 12:1561-1570

Published Date: 24 June 2016

Quality of life and parental styles assessed by adolescents suffering from inflammatory bowel diseases and their parents

Jelenova D, Prasko J, Ociskova M, Latalova K, Karaskova E, Hruby R, Kamaradova D, Mihal V

Neuropsychiatric Disease and Treatment 2016, 12:665-672

Published Date: 23 March 2016

Cognitive behavioral therapy in pharmacoresistant obsessive–compulsive disorder

Vyskocilova J, Prasko J, Sipek J

Neuropsychiatric Disease and Treatment 2016, 12:625-639

Published Date: 14 March 2016

Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders

Ociskova M, Prasko J, Kamaradova D, Grambal A, Kasalova P, Sigmundova Z, Latalova K, Vrbova K

Neuropsychiatric Disease and Treatment 2015, 11:1191-1201

Published Date: 15 May 2015

Readers of this article also read:

Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study

Hashimoto T, Sakurai D, Oda Y, Hasegawa T, Kanahara N, Sasaki T, Komatsu H, Takahashi J, Oiwa T, Sekine Y, Watanabe H, Iyo M

Neuropsychiatric Disease and Treatment 2015, 11:3031-3040

Published Date: 10 December 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010